Skip to main content
placeholder image

Phase 1 study of infusional or bolus deflexifol (a novel formulation of 5FU, folinic acid, and cyclodextrin) after failure of standard treatment.

Journal Article


Abstract


UOW Authors


  •   Aghmesheh, Morteza (external author)
  •   Brungs, Daniel
  •   Clingan, Phillip (external author)
  •   De Souza, Paul (external author)
  •   Ranson, Marie

Publication Date


  • 2017

Citation


  • Clingan, P. R., Ackland, S. P., Ranson, M., De Souza, P., Tafreshi, A., Aghmesheh, M., . . . Jokela, R. (2017). Phase 1 study of infusional or bolus deflexifol (a novel formulation of 5FU, folinic acid, and cyclodextrin) after failure of standard treatment.. Journal of Clinical Oncology, 35(4_suppl), tps812. doi:10.1200/jco.2017.35.4_suppl.tps812

Web Of Science Accession Number


Start Page


  • tps812

End Page


  • tps812

Volume


  • 35

Issue


  • 4_suppl

Abstract


UOW Authors


  •   Aghmesheh, Morteza (external author)
  •   Brungs, Daniel
  •   Clingan, Phillip (external author)
  •   De Souza, Paul (external author)
  •   Ranson, Marie

Publication Date


  • 2017

Citation


  • Clingan, P. R., Ackland, S. P., Ranson, M., De Souza, P., Tafreshi, A., Aghmesheh, M., . . . Jokela, R. (2017). Phase 1 study of infusional or bolus deflexifol (a novel formulation of 5FU, folinic acid, and cyclodextrin) after failure of standard treatment.. Journal of Clinical Oncology, 35(4_suppl), tps812. doi:10.1200/jco.2017.35.4_suppl.tps812

Web Of Science Accession Number


Start Page


  • tps812

End Page


  • tps812

Volume


  • 35

Issue


  • 4_suppl